Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)
Lithium
44.03
(0.23%)
Gold
2,665.30
0.07%
Copper
4.34
(1.42%)
Oil
70.67
(1.17%)
Bitcoin
65,909.08
(0.23%)
FTSE 100
8,259.68
(0.4%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
43,065.22
0.62%
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.13%)
Hang Seng
20,318.79
(3.46%)

OncoSil Medical (ASX: OSL) Treatment Expands in Northern Europe

Three patients have been treated with the OncoSil™ device in the Netherlands at the PANCOSIL Investigator-Initiated Clinical Trial. The trials are being conducted at the AMC Medical Centre in Amsterdam in collaboration with OncoSil Medical. 

This Trial tests the safety and feasibility of percutaneous radionuclide therapy (RNT), a form of treatment that can be performed with the OncoSil™ device in patients with advanced pancreatic cancer.  Over 20 patients are expected to be treated in this controlled trial, using the OncoSil™ device by percutaneous application throughout the PANCOSIL Trial. 

Who is Pancosil 

PANCOSIL is a Netherlands-based investigator-initiated clinical Trial set up in collaboration with OncoSil Medical. It is looking at the safety and feasibility of the percutaneous radionuclide therapy (RNT) with the OncoSil™ device. The aim is to ensure that interventional radiology and oncology can use the OncoSil™ device to treat patients. 

What is Percutaneous radionuclide therapy (RNT)

During the RNT procedure, a radioactive agent is delivered through internal radiation directly to the tumor using the Oncosil device. Internal radiation is better because it makes it possible to deliver “higher radiation doses” without sparring surrounding tissues. 

Is there any progress with Oncosil’s medical trials? 

  • Control trials lend legitimacy to Oncosil, which could accelerate approval by regulators. 
  • Faster approvals will increase the adoption of OncoSil across cancer treatment classes across the world. 
  • Faster commercialisation will increase net revenues - as it has in the past - allowing the company to break even sooner. 
  • Return on investment (ROI) to rise and the share price could recover in a sustained manner. 

 

Three patients have been treated with the OncoSil™ device in the Netherlands in a process known as the Percutaneous Radionuclide Therapy (RNT) that targets radioactive agents to the cell internally without impacting surrounding tissue. This is good news for OncoSil devices and the results of the control trials will improve OncoSil’s marketability and competitiveness. 


Author

  • James Turner

    James Turner is a skilled economist and fund manager with extensive experience in the investment sector. Known for his strategic thinking and analytical skills, James has played a key role in the success of many investment portfolios. In addition to his financial work, he writes about market trends and shares his insights through various publications.

    View all posts
2 Comments
Inline Feedbacks
View all comments
Austin Webb
Austin Webb
4 months ago
Rishad
4 months ago

 Interesting approach with the radioactive agent. Will be curious to see how effective it is compared to traditional treatments

Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions